Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q4 EPS of ($0.47), $0.04 worse than the analyst estimate of ($0.43).

For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.